Estimaciones de analistas de Wall Street para Calumet Inc. (CLMT): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-06 | $1.55 | ||
| 2026-08-07 | $-1.09 | $0.07 | -1717.0% |
| 2026-05-08 | $-3.64 | $-0.57 | -538.6% |
| 2026-02-27 | $-0.43 | $-0.67 | +35.8% |
| 2025-11-07 | $-3.61 | $-0.35 | -930.9% |
| 2025-08-08 | $-1.70 | $-0.44 | -286.4% |
| 2025-05-09 | $-1.87 | $-0.41 | -356.1% |
| 2025-02-28 | $-0.47 | $-1.06 | +55.7% |
Ratios de valoración
| Precio / Valor contable | -4.48 |
| EV / EBITDA | 17.02 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $3.60B | $3.76B | $3.50B | $3.45B | $2.27B | $3.15B | $4.69B | $4.18B | $4.19B | $4.14B |
| Coste de Ventas | $3.19B | $3.27B | $3.06B | $3.00B | $2.17B | $3.01B | $4.33B | $3.73B | $3.96B | $3.89B |
| Beneficio Bruto | $408.3M | $498.2M | $436.7M | $451.7M | $99.1M | $142.9M | $351.7M | $451.7M | $230.8M | $245.7M |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $390.5M | $341.5M | $317.9M | $312.7M | $138.9M | $203.9M | $197.3M | $187.9M | $201.2M | $171.7M |
| Gastos Operativos | $412.3M | $368.9M | $318.6M | $375.4M | $171.0M | $228.5M | $219.8M | $184.5M | $222.7M | $191.5M |
| Beneficio Operativo | -$39.7M | $158.0M | $122.9M | $76.3M | -$71.9M | -$85.6M | $131.9M | $267.2M | $8.1M | $54.2M |
| EBITDA | -$39.7M | $330.8M | $236.1M | $201.6M | $83.1M | $15.6M | $104.3M | $418.2M | $164.5M | $238.4M |
| Gastos por Intereses | $161.7M | $183.1M | $155.5M | $134.6M | $125.9M | $149.5M | $175.9M | $221.7M | $236.7M | $216.0M |
| Beneficio Antes de Impuestos | -$336.3M | -$31.4M | -$50.3M | -$43.1M | -$147.9M | -$258.6M | -$169.9M | $49.7M | -$221.2M | -$126.4M |
| Impuestos | -$7.7M | -$100000 | $700000 | $500000 | $1.1M | $1.5M | $3.4M | $1.6M | $800000 | -$92.6M |
| Beneficio Neto | -$328.6M | -$103.8M | -$55.1M | -$43.6M | -$149.0M | -$254.9M | -$169.8M | $48.1M | -$222.0M | -$33.8M |
| BPA | $-4.27 | $-1.34 | $-0.71 | $-0.56 | $-1.86 | $-3.23 | $-2.14 | $0.59 | $-2.67 | $-0.39 |
| BPA Diluido | $-4.27 | $-1.34 | $-0.71 | $-0.56 | $-1.86 | $-3.23 | $-2.14 | $0.59 | $-2.67 | $-0.39 |
| Acciones en Circulación (Diluidas) | $77.0M | $77.6M | $77.9M | $78.2M | $78.4M | $79.0M | $79.3M | $80.1M | $83.1M | $86.8M |
Precio
| Precio | $58.01 |
| Capitalización | $5.1B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: BKV · BTE · EFXT · GEL · GLP · NEXT · NOG
Explorar sector: Basic Materials · Chemicals - Specialty
Más secciones de CLMT: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones